What is the current Price Target for the I-Mab - ADR stock?

The average I-Mab - ADR target price is $5.67. This is 529.63% higher than the current stock price. The highest price target is 788.89%, the lowest is 344.44%. 3 Analysts have issued a price target I-Mab - ADR 2026 .

How high will the I-Mab - ADR stock rise?

No reliable answer can be given as to how high the I-Mab - ADR stock will rise. The performance of stocks, including the I-Mab - ADR stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the I-Mab - ADR stock today?

The performance of I-Mab - ADR stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the I-Mab - ADR stock fall?

The decline in I-Mab - ADR stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

I-Mab - ADR Forecast, price target & analysts

$0.93

3.32% today

Nasdaq, Feb 28, 08:17 pm CET

ISIN

US44975P1030

Symbol

IMAB

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

I-Mab - ADR Target price 2025 - Analyst rating & recommendation

I-Mab - ADR Classifications & Recommendation:

Buy

100%

I-Mab - ADR Price Target

Target Price	$5.67
Price	$0.90
Potential	529.63% register free of charge
Number of Estimates	3

	3 Analysts have issued a price target I-Mab - ADR 2026 . The average I-Mab - ADR target price is $5.67. This is 529.63% register free of charge higher than the current stock price. The highest price target is $8.00 788.89% register free of charge , the lowest is $4.00 344.44% register free of charge .
	A rating was issued by 3 analysts: 3 Analysts recommend I-Mab - ADR to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the I-Mab - ADR stock has an average upside potential 2026 of 529.63% register free of charge . Most analysts recommend the I-Mab - ADR stock at Purchase.

Current I-Mab - ADR Upgrades & Downgrades Beta

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Nov 15 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Sep 17 2024
HC Wainwright & Co.	Locked ➜ Locked	Locked	Aug 29 2024

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Nov 15 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Sep 17 2024
Locked HC Wainwright & Co.: Locked ➜ Locked	Aug 29 2024

Discover more stocks with a high price target

Coinbase Global, Inc. 60.51%

BioNTech SE - ADR 30.07%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now

The Apple stock at a glance with charts, current key metrics, news and stock analyses.

The Best Dividend Stocks in the Dividend Top Scorer list.

Stock Analyses of the Best Stocks Worldwide.

Start building wealth today